Those who work daily with different documents know very well how much efficiency depends on how convenient it is to use editing instruments. When you patent documents have to be saved in a different format or incorporate complex components, it might be challenging to handle them using conventional text editors. A simple error in formatting may ruin the time you dedicated to link age in patent, and such a simple job shouldn’t feel challenging.
When you find a multitool like DocHub, such concerns will never appear in your work. This powerful web-based editing solution will help you quickly handle documents saved in patent. It is simple to create, modify, share and convert your files anywhere you are. All you need to use our interface is a stable internet access and a DocHub profile. You can create an account within minutes. Here is how easy the process can be.
With a well-developed editing solution, you will spend minimal time finding out how it works. Start being productive the moment you open our editor with a DocHub profile. We will ensure your go-to editing instruments are always available whenever you need them.
Good morning everyone. My name is Elaine Woo and I'm one of the principal councils or directors of the China team of IP experts here at the USPTO's Office of Policy International Affairs. I would like to welcome everyone to this webinar on biopharma patents in China litigation licensing and patent linkage. According to industry sources, China is the world's second largest biopharmaceutical market and continues to grow at a fast pace, particularly as the country's growing wealth and rapidly aging population creates strong demand for health care products in an increasing number of diseases including cancers, cardiovascular diseases and diabetes. The increase of China's by Chinese biopharma companies of reflects the industry's growth and potential and why company formation decline in other major markets. More than 140 new biotech companies emerged in China from 2010. To 2020, in recognizing this potential, China's policymakers have embarked on a mission to advance the industry by enactin...